AVEO PHARMACEUTICALS INC 4
4 · AVEO PHARMACEUTICALS INC · Filed Jun 26, 2013
Insider Transaction Report
Form 4
Gyuris Jeno
SVP, Head of Research
Transactions
- Award
Stock Option (right-to-buy)
2013-06-26+120,000→ 120,000 totalExercise: $2.51From: 2014-07-01Exp: 2023-06-26→ Common Stock (120,000 underlying) - Award
Common Stock
2013-06-26+40,000→ 151,245 total
Footnotes (2)
- [F1]The shares underlying such award are subject to a right of repurchase by the issuer under specified circumstances, including upon the cessation of employment, which repurchase right lapses based upon the achievement of certain strategic performance objectives, as determined by the issuer's compensation committee.
- [F2]These options vest and become exercisable over a period of two years, with 40% becoming exercisable on July 1, 2014 and the remaining 60% becoming exercisable on July 1, 2015, provided that the applicable executive officer continues to be employed by the issuer as of the applicable vesting date.